 |
Pegylated arginine deiminase |
|---|---|
| Trade Name | Melanocid |
| Orphan Indication | Invasive malignant melanoma |
| USA Market Approval | USA |
| USA Designation Date | 1999-04-12 00:00:00 |
| Sponsor | Polaris Pharmaceuticals, Inc.;A Polaris Group Company, Suite 106;San Diego, California, 92121 |
